ASBP
Aspire Biopharma
ASBP
ASBP
19 hedge funds and large institutions have $17.9M invested in Aspire Biopharma in 2023 Q4 according to their latest regulatory filings, with 3 funds opening new positions, 1 increasing their positions, 2 reducing their positions, and 1 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more funds holding
Funds holding: →
more ownership
Funds ownership: →
less capital invested
Capital invested by funds: $ → $
50% less repeat investments, than reductions
Existing positions increased: 1 | Existing positions reduced: 2
Holders
19
Holding in Top 10
1
Calls
–
Puts
–
Top Buyers
| 1 | +$382K | |
| 2 | +$342K | |
| 3 | +$184K | |
| 4 |
QL
Quarry LP
New York
|
+$13.2K |
Top Sellers
| 1 | -$376K | |
| 2 | -$289K | |
| 3 | -$210K | |
| 4 |
UBS Group
Zurich,
Switzerland
|
-$650 |
| 5 |
TRCT
Tower Research Capital (TRC)
New York
|
-$87 |